Appearance of oral erosive lichen planus during interferon alfa-2a therapy for chronic active hepatitis C.
Núñez
M
M
Miralles
E S
ES
de las Heras
M E
ME
Ledo
A
A
D005260:Female; D006526:Hepatitis C / Q000628:therapy*; D006521:Hepatitis, Chronic / Q000628:therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008010:Lichen Planus / Q000209:etiology*; D008875:Middle Aged; D009059:Mouth Diseases / Q000209:etiology*; D009061:Mouth Mucosa / Q000473:pathology; D011994:Recombinant Proteins; D014060:Tongue Diseases / Q000209:etiology
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins